Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06596759 · ClinicalTrials.gov registry record · NA
Diaphragmatic Breathing for the Treatment of Bloating and Distension
A NA study of Bloating, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06596759: Recruiting NA study of Bloating, sponsored by Mayo Clinic.
NCT06596759 is a NA study of Bloating that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 35 participants, below the 96-participant average among 5 other Bloating trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06596759, a NA study of Bloating, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy of diaphragmatic breathing using the validated Mayo Bloating Questionnaire.
Primary Outcome
The Mayo Bloating Questionnaire is a 45-item questionnaire developed to measure the multiple symptom components of bloating and distension.
Conditions Studied
Interventions
- BEHAVIORAL Diaphragmatic Breathing
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2026-05-30 |
| Phase | NA |
What NCT06596759 shows while recruiting
NCT06596759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 96-participant average among 5 other Bloating trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Bloating appearing as the primary indexed condition, and to 1 intervention - of which Diaphragmatic Breathing is the first listed.
NCT06596759 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06596759 about?
NCT06596759 is a clinical study titled "Diaphragmatic Breathing for the Treatment of Bloating and Distension". The purpose of this study is to evaluate the efficacy of diaphragmatic breathing using the validated Mayo Bloating Questionnaire.
What is the current status of trial NCT06596759?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2024-10-21. Estimated completion is 2026-05-30.
What conditions does trial NCT06596759 study?
This clinical trial studies the following conditions: Bloating.
What interventions are being tested in trial NCT06596759?
The interventions under investigation include: Diaphragmatic Breathing (BEHAVIORAL).
Who is sponsoring clinical trial NCT06596759?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06596759 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bloating
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women
RECRUITING · NA
-
Study to Evaluate a Probiotic in Healthy Subjects With a History of Abdominal Discomfort and Bloating
COMPLETED · NA
-
Treatment of Symptomatic Bloating Using a Novel Hypnotherapy Protocol
COMPLETED · NA
-
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
RECRUITING · Phase 2
-
A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI